Table 1 Characteristics of the study participants
From: Skin perfusion pressure predicts mortality in hemodialysis patients: long term follow-up
All patients (n = 45) | |
Age (years) | 62.7 ± 12.4 |
Gender (m/f) | 31:14 |
Duration of hemodialysis (years) | 7.3 ± 5.1 |
Quantity of blood flow (ml/min) | 202.7 ± 24.4 |
Dialysis time (h) | 4.0 ± 0.4 |
Primary cause of ESKD, n (%) | |
Diabetic nephropathy | 17 (38.0) |
Chronic glomerulonephritis | 17 (38.0) |
Nephrosclerosis | 2 (4.4) |
Polycystic kidney disease | 2 (4.4) |
Unknown and others | 7 (15.6) |
Current smoking, n (%) | 5 (11.1) |
Medication, n (%) | |
Statin | 5 (11.5) |
Cilostazol | 5 (8.9) |
Hemoglobin (g/dI) | 10.1 ± 1.0 |
Albumin (f/dI) | 4.1 ± 0.4 |
Ca (mg/dI) | 9.4 ± 0.7 |
P (mg/dI) | 5.1 ± 1.2 |
BUN (mg/dI) | 69.3 ± 12.4 |
Cre (mg/dI) | 10.9 ± 2.0 |
i-PTH (pg/dI) | 176.9 ± 112.0 |
LVD (mm) | 51.1 ± 5.1 |
LVEF (%) | 66.6 ± 9.0 |